Selected Recent Publications
Yam GH, Yang T, Geary ML, Santra M, Funderburgh M, Rubin E, Du Y, Sahel JA, Jhanji V, Funderburgh JL. Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p - A robust cell selection tool for stem cell therapy of corneal scarring. J Adv Res. 2023 Mar;45:141-155. doi: 10.1016/j.jare.2022.05.008. Epub 2022 May 25. PubMed PMID: 35623612; PubMed Central PMCID: PMC10006527.
Gupta U, Ghosh S, Wallace CT, Shang P, Xin Y, Nair AP, Yazdankhah M, Strizhakova A, Ross MA, Liu H, Hose S, Stepicheva NA, Chowdhury O, Nemani M, Maddipatla V, Grebe R, Das M, Lathrop KL, Sahel JA, Zigler JS Jr, Qian J, Ghosh A, Sergeev Y, Handa JT, St Croix CM, Sinha D. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy. 2023 Jan;19(1):92-111. doi: 10.1080/15548627.2022.2062887. Epub 2022 Apr 26. PubMed PMID: 35473441; PubMed Central PMCID: PMC9809950.
Vienola KV, Zhang M, Snyder VC, Dansingani KK, Sahel JA, Rossi EA. Near infrared autofluorescence imaging of retinal pigmented epithelial cells using 663 nm excitation. Eye (Lond). 2022 Oct;36(10):1878-1883. doi: 10.1038/s41433-021-01754-0. Epub 2021 Aug 30. PubMed PMID: 34462582; PubMed Central PMCID: PMC9499940.
Koretz ZA, Apostolopoulou A, Chen E, Beale O, Veldkamp P, Viehman JA, Sahel JA, Chhablani J, Dansingani KK, Errera MH, Bonhomme GR. Clinical Features and Multimodal Imaging in Atypical Posterior Uveitis Secondary to Bartonella Henselae Infection. Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):2047-2054. doi: 10.1080/09273948.2021.1961812. Epub 2021 Aug 17. PubMed PMID: 34402723.
Williams AM, Sahel JA. Addressing Social Determinants of Vision Health. Ophthalmol Ther. 2022 Aug;11(4):1371-1382. doi: 10.1007/s40123-022-00531-w. Epub 2022 Jun 8. Review. PubMed PMID: 35674883; PubMed Central PMCID: PMC9174922.
Parker MA, Erker LR, Audo I, Choi D, Mohand-Said S, Sestakauskas K, Benoit P, Appelqvist T, Krahmer M, Ségaut-Prévost C, Lujan BJ, Faridi A, Chegarnov EN, Steinkamp PN, Ku C, da Palma MM, Barale PO, Ayelo-Scheer S, Lauer A, Stout T, Wilson DJ, Weleber RG, Pennesi ME, Sahel JA, Yang P. Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5. Am J Ophthalmol. 2022 Aug;240:285-301. doi: 10.1016/j.ajo.2022.02.013. Epub 2022 Mar 4. PubMed PMID: 35248547; PubMed Central PMCID: PMC9308722.